HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sabina Signoretti Selected Research

Sabina Signoretti Research Topics

Disease

112Neoplasms (Cancer)
11/2022 - 01/2002
66Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 04/2005
16Hypoxia (Hypoxemia)
01/2019 - 08/2004
15Kidney Neoplasms (Kidney Cancer)
01/2022 - 05/2005
14Prostatic Neoplasms (Prostate Cancer)
01/2022 - 03/2004
12Carcinogenesis
12/2019 - 06/2002
10Neoplasm Metastasis (Metastasis)
01/2020 - 02/2011
7Disease Progression
01/2022 - 01/2007
7Breast Neoplasms (Breast Cancer)
11/2016 - 09/2002
6Carcinoma (Carcinomatosis)
01/2020 - 06/2011
6Adenocarcinoma
03/2015 - 07/2008
4Melanoma (Melanoma, Malignant)
01/2019 - 08/2004
4Necrosis
07/2016 - 08/2004
4Prostatic Intraepithelial Neoplasia
01/2013 - 06/2002
3Lung Neoplasms (Lung Cancer)
12/2019 - 04/2005
3Body Weight (Weight, Body)
06/2009 - 07/2006
2Tics (Tic)
01/2021 - 01/2019
2Testicular Neoplasms (Testicular Cancer)
01/2016 - 01/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016 - 12/2015

Drug/Important Bio-Agent (IBA)

29Biomarkers (Surrogate Marker)IBA
11/2022 - 06/2008
17Proteins (Proteins, Gene)FDA Link
11/2020 - 09/2002
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2016 - 01/2007
10Sunitinib (Sutent)FDA Link
01/2021 - 05/2009
9Immune Checkpoint InhibitorsIBA
10/2021 - 01/2018
8EverolimusFDA Link
01/2022 - 05/2014
8AndrogensIBA
01/2022 - 05/2003
8Pharmaceutical PreparationsIBA
01/2021 - 05/2005
8Transcription Factors (Transcription Factor)IBA
01/2019 - 07/2005
8Carbonic Anhydrase IXIBA
06/2016 - 05/2005
8Sorafenib (BAY 43-9006)FDA Link
11/2013 - 08/2007
7B7-H1 AntigenIBA
01/2022 - 02/2015
7NivolumabIBA
01/2022 - 12/2015
7Phosphotransferases (Kinase)IBA
01/2017 - 08/2008
6MTOR InhibitorsIBA
01/2022 - 01/2007
6RNA (Ribonucleic Acid)IBA
01/2022 - 01/2015
6Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2022 - 08/2007
6Interleukin-2 (IL2)IBA
05/2017 - 05/2005
6DNA (Deoxyribonucleic Acid)IBA
01/2016 - 11/2012
5cabozantinibIBA
01/2022 - 01/2017
5Histone DemethylasesIBA
12/2019 - 08/2011
5EnzymesIBA
05/2014 - 03/2009
4Mechanistic Target of Rapamycin Complex 1IBA
01/2022 - 07/2010
4Bevacizumab (Avastin)FDA Link
01/2020 - 05/2009
4temsirolimusFDA Link
01/2020 - 09/2007
4Sirolimus (Rapamycin)FDA Link
07/2019 - 07/2010
4ParaffinIBA
10/2017 - 08/2004
4AntibodiesIBA
05/2017 - 06/2015
4Fatty Acid Synthases (Fatty Acid Synthase)IBA
10/2016 - 03/2004
4TOR Serine-Threonine KinasesIBA
08/2016 - 01/2007
4AntigensIBA
01/2016 - 06/2011
4Protein Isoforms (Isoforms)IBA
03/2015 - 06/2009
3Biological ProductsIBA
01/2021 - 10/2016
3Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
07/2019 - 06/2010
3Messenger RNA (mRNA)IBA
10/2016 - 07/2013
3Cisplatin (Platino)FDA LinkGeneric
05/2016 - 06/2014
3pazopanibFDA Link
03/2015 - 09/2013
3Hormones (Hormone)IBA
01/2015 - 06/2006
3Doxorubicin (Adriamycin)FDA LinkGeneric
06/2014 - 05/2005
3Phenobarbital (Luminal)FDA Link
12/2012 - 05/2003
3Cyclin D1IBA
10/2012 - 07/2010
3Angiogenesis InhibitorsIBA
10/2010 - 08/2007
3Androgen Receptors (Androgen Receptor)IBA
04/2009 - 12/2004
2Von Hippel-Lindau Tumor Suppressor ProteinIBA
01/2022 - 12/2017
2IpilimumabIBA
01/2022 - 01/2021
2InterferonsIBA
01/2022 - 05/2009
2Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2017
2Retinoblastoma ProteinIBA
12/2019 - 08/2011
2dactolisibIBA
07/2019 - 07/2010
2Histones (Histone)IBA
01/2019 - 08/2011
2Programmed Cell Death 1 ReceptorIBA
01/2019 - 02/2018
2LipidsIBA
01/2019 - 01/2018
2LigandsIBA
01/2018 - 12/2016
2Formaldehyde (Formol)FDA Link
10/2017 - 08/2004
2aldesleukin (Proleukin)FDA Link
05/2017 - 02/2015
2UbiquitinIBA
11/2016 - 09/2002
2Ligases (Synthetase)IBA
11/2016 - 09/2002
2Fatty Acids (Saturated Fatty Acids)IBA
10/2016 - 06/2009
2Fumarate Hydratase (Fumarase)IBA
01/2016 - 03/2009
2MicroRNAs (MicroRNA)IBA
01/2016 - 07/2013
2N 30IBA
01/2016 - 04/2010
2Oxygen (Dioxygen)IBA
01/2016 - 09/2010
2Oncogene Proteins (Oncogene Protein)IBA
08/2014 - 08/2011
2Lactate Dehydrogenase 5IBA
05/2014 - 03/2009
2Lactic Acid (Lactate)FDA LinkGeneric
05/2014 - 03/2009
2Pyruvic Acid (Pyruvate)IBA
05/2014 - 03/2009
2AgarIBA
12/2013 - 04/2009
2Phosphatidylinositols (Phosphatidylinositol)IBA
11/2013 - 07/2005
2CytokinesIBA
12/2012 - 12/2011
2Cyclin-Dependent Kinase Inhibitor p16IBA
11/2012 - 01/2002
2Prostate-Specific Antigen (Semenogelase)IBA
02/2011 - 06/2006
2Paclitaxel (Taxol)FDA LinkGeneric
12/2010 - 06/2009
2TensinsIBA
06/2010 - 09/2007

Therapy/Procedure

57Therapeutics
01/2022 - 09/2002
8Immunotherapy
11/2022 - 01/2016
6Radiofrequency Ablation
12/2010 - 04/2005
4Castration
01/2022 - 06/2006
3Precision Medicine
10/2018 - 06/2008
3Drug Therapy (Chemotherapy)
10/2014 - 12/2010
2Nephrectomy
02/2015 - 01/2013
2Aftercare (After-Treatment)
12/2010 - 04/2010